DoW Breast Cancer, Clinical Research Extension Award
DoW Breast Cancer, Clinical Research Extension Award is offered by Defense Health Agency Contracting Activity - DHACA. Max award: Not specified. Applications close on Nov 18, 2026.
| Opportunity number | HT942526BCRPCREA2 |
|---|---|
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Posted |
| Posted | Sep 3, 2026 |
| Closes | Nov 18, 2026 |
| Award ceiling | Not specified |
| Award floor | Not specified |
| Total program funding | $8,400,000 |
| Expected awards | 1 |
| Who can apply | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Category | Science and Technology and other Research and Development |
Summary (excerpt)
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from Defense Health Agency Contracting Activity - DHACA